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 genetic polymorphisms have been associated with
type 1 diabetes. We genotyped 207 patients and 249
controls for the most frequently investigated poly-









significant differences were observed, suggesting that
this polymorphism is not strongly associated with type 1




CTLA4 is a member of the immunoglobulin superfamily
that is expressed on the surface of activated T cells and














and have been associated with different susceptibilities to









., 2005). Most molecular epidemiology studies





nucleotide polymorphism (SNP) that causes a threonine-to-
alanine substitution in codon 17 and is associated with

















., 2002). This polymorphism seems
to be associated with the genetic susceptibility to type 1
diabetes in several populations, although conflicting data
also exist in populations of different ethnic backgrounds
(Kavvoura & Ioannidis, 2005). The replication of results
in populations of different ethnic backgrounds is important
to confirm the association between the disease and the
specific polymorphism, regardless of the genetic back-
ground of the population.





 polymorphism to the susceptibility to type 1




The study was designed as a retrospective case–control
study involving 207 Caucasian Portuguese patients with













 10.2 years) that
attended the outpatient clinics at the University Hospital
of Coimbra (Portugal). Patients had been diagnosed on
the basis of classical clinical presentation, low or undetec-
table levels of serum C-peptide, and presence of one or more
autoantibodies (islet cell autoantibodies, autoantibodies
to insulin, autoantibodies to glutamic acid decarboxylase
(GAD65) or autoantibodies to the tyrosine phosphatase









 SD). The control group consisted of 249 unrelated












 13.8 years) which were blood donors and hospital
and faculty staff, from the same geographical region. Informed
consent was obtained from patients and controls.
Leucocyte DNA was isolated from peripheral blood














The Pearson’s chi-square test of independence, with
one degree of freedom, was used to examine differences
of genotype and allele frequencies between patients




-values were calculated, and






 0.05. Odds ratios
(OR) and the corresponding 95% confidence intervals (CI)
were calculated for each genotype and allele. Subgroup
analysis, according to the presence or absence of each
of the autoantibodies, was carried out using the same
method. Hardy–Weinberg equilibriums were assessed by
use of the chi-square goodness-of-fit test to compare the
observed and allele-based expected genotype frequencies.
Power calculation was analysed using the program Power









 genotype and allele frequencies
did not differ significantly between patients with type 1
diabetes mellitus and controls (Table 1). No single genotype
or allele was associated with an altered risk for type 1
diabetes mellitus. Odds ratios for the putative high risk
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respectively. No correlation was found between genotype
and presence of each of the autoantibodies (data not shown).
All frequencies were in Hardy–Weinberg equilibrium.
Power analysis showed that the study sample size was
sufficient to detect an OR of 1.47 associated with the G










on the susceptibility to type 1 diabetes in the Portuguese





 gene in the pathogenesis of type 1 diabetes in
our population. This contrasts with positive associations





case–control studies in populations from Belgium, Germany,
Poland, France, Japan, China, Italy, the Philippines, Lebanon,








., 2004; Kavvoura &








., 2005). A meta-analysis





an increased risk for type 1 diabetes, with an OR of 1.45
(95% CI 1.28–1.65) (Kavvoura & Ioannidis, 2005). How-





has also been reported in populations from the USA, Japan,
Ghana, UK, France, Czech Republic, Morocco, Argentina,



































The apparent discrepancies between the present study
and other studies could be due to the genetic heterogeneity
among the populations studied, to different interactions
with environmental factors involved in the pathogenesis of
type 1 diabetes, to limited individual study power or to other









SNP may not be the true disease-associated variant, but
rather a marker in linkage disequilibrium with the causal
variant, and the discrepant findings may reflect variable
strengths of linkage disequilibrium in different populations.




49A/G polymorphism because it




 variant in type 1
diabetes patients from several ethnic populations (Kavvoura
& Ioannidis, 2005). In addition, it is the only known SNP
that causes an amino acid change (threonine to alanine),






















-untranslated region (UTR) of the gene, such




6230G/A, rs3087243) SNP, might also affect
protein expression and influence the risk of immune-


































Our study was powered to detect an association, of
about the same magnitude that has been reported in type 1
diabetes (Kavvoura & Ioannidis, 2005); however, a more




49A/G polymorphism on susceptibility
cannot be excluded in the present study.








 gene is not strongly associated




This work was supported by ‘Bolsa Dr M. M. Almeida
Ruas — Sociedade Portuguesa de Diabetologia/Novo




Ahmedov, G., Ahmedova, L., Sedlakova, P. & Cinek, O. (2006) 
Genetic association of type 1 diabetes in an Azerbaijanian 










Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M.C. & 
Polychronakos, C. (2002) A common autoimmunity predisposing 
signal peptide variant of the cytotoxic T-lymphocyte antigen 4 
results in inefficient glycosylation of the susceptibility allele. 
 







Caputo, M., Cerrone, G.E., Lopez, A.P., Villalba, A., Krochik, G.A., 
Cedola, F.N., Targovnik, H.M. & Frechtel, G.D. (2005) 
Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G 










Donner, H., Rau, H., Walfish, P.G., Braun, J., Siegmund, T., 
Finke, R., Herwig, J., Usadel, K.H. & Badenhoop, K. (1997) 
CTLA4 alanine-17 confers genetic susceptibility to Graves’ 
disease and to type 1 diabetes mellitus. 
 








Dupont, W.D. & Plummer, W.D. (1997) PS power and sample size 









Gough, S.C., Walker, L.S. & Sansom, D.M. (2005) CTLA4 gene 










Hauache, O.M., Reis, A.F., Oliveira, C.S., Vieira, J.G., Sjoroos, M. 
& Ilonen, J. (2005) Estimation of diabetes risk in Brazilian 
population by typing for polymorphisms in HLA-DR-DQ, 









Kavvoura, F.K. & Ioannidis, J.P. (2005) CTLA-4 gene polymorphisms 
and susceptibility to type 1 diabetes mellitus: a HuGE review 
and meta-analysis. 
 







Marron, M.P., Raffel, L.J., Garchon, H.J., Jacob, C.O., 





Insulin-dependent diabetes mellitus (IDDM) is associated 









Table 1. CTLA4 +49A/G genotype and allele frequencies in patients 







(95% CI) P value
Genotype n (%) n (%)
AA 111 (44.6) 82 (39.6) 0.82 (0.56–1.19) 0.285
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Allele
A 330 (66.3) 259 (62.6) 0.85 (0.65–1.12) 0.244
G 168 (33.7) 155 (37.4) 1.18 (0.90–1.54) 0.244
n, number; CI, confidence interval.
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